StemBioSys Scientist, Anne Sheldrake, was invited to speak at Texas Public Radio’s first “Worth Repeating” event of their 5th season. She shared her story of confronting a mental health issue while pursuing a PhD. It is important to share these stories in the biosciences industry as graduate student mental health is too often ignored. Anne confronted and overcame an eating disorder, and for the last 2 years has been a key driver of innovation and new product development at StemBioSys. Anne, thank you for sharing your story.
CELLvo™ Matrix has recently been shown to improve the isolation and expansion of human chondrocytes, while minimizing significant change in phenotype . Here, we compare gene expression of CELLvo™ Human Articular Chondrocytes (HC-A) to other commercially available articular chondrocyte products. Additionally, we examine the effect of culture on substrate choice (CELLvo™ Chondrocyte-Derived (CD) Matrix (in development) vs. tissue culture plastic (TCP)) on chondrocyte gene expression. We show that CELLvo™ HC-A are the only chondrocytes with a native phenotype, and that CELLvo™ CD Matrix minimizes loss of phenotype during in vitro expansion.
The focus sessions, posters, plenary sessions, and innovation showcases spanned a wide array of topics, but a common theme was that a more nuanced understanding of cell biology has created an appropriate demand for more detailed and relevant data and models.